NCT05872516

Brief Summary

Chang Gung Atrial Fibrillation Detection Software is an artificial intelligence electrocardiogram signal analysis software that detects whether a patient has atrial fibrillation by static 12-lead ECG signals. This study is a non-inferiority test based on the control group. The main purpose is to verify whether Chang Gung atrial fibrillation detection software can correctly identify atrial fibrillation in patients with atrial fibrillation, and can be used to provide a reference for doctors to detect atrial fibrillation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
788

participants targeted

Target at P75+ for not_applicable atrial-fibrillation

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 11, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2023

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 24, 2023

Completed
Last Updated

May 24, 2023

Status Verified

April 1, 2023

Enrollment Period

7 months

First QC Date

May 4, 2023

Last Update Submit

May 14, 2023

Conditions

Keywords

artificial intelligence

Outcome Measures

Primary Outcomes (1)

  • Sensitivity

    The rate of test results that correctly indicate the presence.

    baseline

Secondary Outcomes (7)

  • Specificity

    baseline

  • Accuracy

    baseline

  • Area Under the receiver operating characteristic Curve

    baseline

  • Positive predictive value

    baseline

  • Negative predictive value

    baseline

  • +2 more secondary outcomes

Study Arms (1)

Software diagnosis

EXPERIMENTAL

Software diagnosis with gold standard of 3 doctors' consensus.

Device: Chang Gung Atrial Fibrillation Detecting Software

Interventions

This software is expected to be used in clinical testing to interpret the static 12-lead ECG of adults who are over 20 years old and suspected of having atrial fibrillation, detect whether there is a signal of atrial fibrillation, and output the results for clinicians Near-instant auxiliary diagnostic use.

Software diagnosis

Eligibility Criteria

Age20 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Equal or greater than twenty years old
  • Static 12-lead electrocardiogram of General Electric MUSE XML format file.
  • The data comes from the static 12-lead electrocardiogram device of General Electric (model MAC5500).
  • The electrocardiogram signal is 500 Hz.
  • The Alternating current (AC) filter of the electrocardiogram signal is 60 Hz.

You may not qualify if:

  • Cases used in the model development process.
  • Lacks any electrode.
  • Contain any electrode lacks a segment.
  • Misplaced leads

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung memorial hospital

Taoyuan, 333, Taiwan

Location

Related Publications (4)

  • Mant J, Fitzmaurice DA, Hobbs FD, Jowett S, Murray ET, Holder R, Davies M, Lip GY. Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ. 2007 Aug 25;335(7616):380. doi: 10.1136/bmj.39227.551713.AE. Epub 2007 Jun 29.

    PMID: 17604299BACKGROUND
  • US Preventive Services Task Force; Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 Aug 7;320(5):478-484. doi: 10.1001/jama.2018.10321.

    PMID: 30088016BACKGROUND
  • Wong KC, Klimis H, Lowres N, von Huben A, Marschner S, Chow CK. Diagnostic accuracy of handheld electrocardiogram devices in detecting atrial fibrillation in adults in community versus hospital settings: a systematic review and meta-analysis. Heart. 2020 Aug;106(16):1211-1217. doi: 10.1136/heartjnl-2020-316611. Epub 2020 May 11.

    PMID: 32393588BACKGROUND
  • Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. No abstract available.

    PMID: 32860505BACKGROUND

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Chang-Fu Kuo, MD/Ph.D

    Associate Professor and Director Division of Rheumatology

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2023

First Posted

May 24, 2023

Study Start

July 11, 2022

Primary Completion

February 8, 2023

Study Completion

April 10, 2023

Last Updated

May 24, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations